1- Except for the PSA test , which is considered as an obsolete tool by more and more urologists, the PCA3 test remains the only non invasive FDA approved test being sold on the american market. The PHI test from Beckman Coulter is still not allowed in the US despite its FDA approval.
2- As for the GCC test, what is going on with Signal Genetics is incomprehensible but that test has no equivalent on the global market and is a relevant response to a huge unmet need. Hopefully an agreement with a trusty partner is expected following the disclosure of the second part of the Vitar study.
Two products without any competitors .
Fantomatus